Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cerebrospinal Fluid Iron Status Predicts Neurocognitive Performance Over Time in Adults with HIV

Harpreet Kaur, William S. Bush, Scott L. Letendre, Ronald J. Ellis, Robert K. Heaton, Stephanie M. Patton, James R. Connor, David C. Samuels, Donald R. Franklin, Todd Hulgan, Asha R. Kallianpur
doi: https://doi.org/10.1101/2020.11.04.20199760
Harpreet Kaur
1Genomic Medicine Institute, Cleveland Clinic/Lerner Research Institute, Cleveland, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William S. Bush
2Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott L. Letendre
3Departments of Medicine and Psychiatry, University of California-San Diego, San Diego, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald J. Ellis
4Departments of Neurology and Psychiatry, University of California-San Diego, San Diego, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert K. Heaton
5Department of Psychiatry, University of California-San Diego, San Diego, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie M. Patton
6Department of Neurosurgery, Pennsylvania State/Hershey College of Medicine, Hershey, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James R. Connor
6Department of Neurosurgery, Pennsylvania State/Hershey College of Medicine, Hershey, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Samuels
7Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald R. Franklin
5Department of Psychiatry, University of California-San Diego, San Diego, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd Hulgan
8Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asha R. Kallianpur
1Genomic Medicine Institute, Cleveland Clinic/Lerner Research Institute, Cleveland, OH, USA
2Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA
9Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kalliaa@ccf.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Iron homeostasis is essential for brain health, and iron is also required for HIV replication, but the role of iron is largely unexplored in HIV-associated neurocognitive disorders. These disorders remain extremely common in people with HIV, despite antiretroviral therapy capable of suppressing viral replication, and they involve damage to white matter tracts and synaptodendritic architecture in the brain. We hypothesized that cerebrospinal fluid (CSF) levels of iron and two proteins involved in iron delivery, mitochondrial function, and protection against iron-mediated oxidative stress (H-ferritin and transferrin) are associated with neurocognitive performance over time in adults with HIV. These CSF iron-related biomarkers were measured at baseline (entry) in 403 adults with HIV from a large, prospective observational study who underwent comprehensive neurocognitive assessments at 6-month intervals. All participants were assigned a Global Deficit Score (GDS) and neurocognitive change status (improving/stable/declining), compared to baseline, at each visit. Biomarker associations with change status, and GDS differences over 30, 36, and 42 months of follow-up, were evaluated by multivariable regression. GDS-defined neurocognitive impairment was present in 120 study participants at entry (29.8%); 73% were on antiretroviral therapy. Of 267 participants with longitudinal follow-up, 16% were improving neurocognitively, and 20% were declining at their last follow-up visit (median 36 months). In multivariable-adjusted analyses, higher baseline CSF H-ferritin predicted improving neurocognitive performance at the last assessment (p=0.029), and a better GDS over at least 30 months. Higher H-ferritin levels were also associated with better GDS-defined neurocognitive performance over 30, 36, and 42 months in virally suppressed individuals (p-values <0.01 at all three time-points) and individuals aged<50 (all p-values <0.05). Higher CSF transferrin beneficially influenced GDS-defined neurocognitive performance at all three follow-up visits (all p<0.05), particularly in viremic individuals and people with HIV aged 50 and over, but the associations lost statistical significance in analyses restricted to virally suppressed persons. Significant multiplicative interactions with comorbidity were observed for both H-ferritin and transferrin in viremic adults. In summary, higher CSF H-ferritin is associated with better neurocognitive performance over time in adults with HIV, particularly in younger and virally suppressed individuals on antiretroviral therapy. Higher CSF transferrin may be particularly neuroprotective in pro-inflammatory settings such as in older and/or viremic people with HIV. Overall, our findings could reflect better iron delivery to neurons and myelinating oligodendrocytes, better mitochondrial function, and reduced oxidative stress under specific scenarios (e.g., viremia/aviremia) of HIV infection, and they may provide a rationale for the use of iron-modulating interventions to prevent or treat neurocognitive decline in people with HIV.

Competing Interest Statement

Authors Kaur, Bush, Letendre, Franklin, Ellis, Hulgan, Heaton, Samuels, and Kallianpur have no potential conflicts of interest to disclose. Author S. Patton is a paid consultant for SideroBiosciences, Inc., and J.R. Connor, a longstanding collaborator, is Chairman of the Board and co-founder of SideroBiosciences, which has a product in clinical trials for treating iron deficiency.

Funding Statement

This work was supported by National Institutes of Health grant 1R01 MH095621 (to AK and TH). The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Study was also supported by National Institutes of Health awards NIH R01 MH107345 (to SL and RH). The authors and their institutions received no payment or services from a third party for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Cleveland Clinic Institutional Review Board approval was given for this analysis, which was considered exempt due to using only completely de-identified data. The CHARTER Study on which the analysis is based has been continuously approved by the IRBs of all six participating institutions. Further details will be provided as needed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding Disclosure: This work was supported by National Institutes of Health grant 1R01 MH095621 (to AK and TH). The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Study was also supported by National Institutes of Health awards NIH R01 MH107345 (to SL and RH).

Data Availability

The dataset analyzed for this manuscript is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cerebrospinal Fluid Iron Status Predicts Neurocognitive Performance Over Time in Adults with HIV
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cerebrospinal Fluid Iron Status Predicts Neurocognitive Performance Over Time in Adults with HIV
Harpreet Kaur, William S. Bush, Scott L. Letendre, Ronald J. Ellis, Robert K. Heaton, Stephanie M. Patton, James R. Connor, David C. Samuels, Donald R. Franklin, Todd Hulgan, Asha R. Kallianpur
medRxiv 2020.11.04.20199760; doi: https://doi.org/10.1101/2020.11.04.20199760
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cerebrospinal Fluid Iron Status Predicts Neurocognitive Performance Over Time in Adults with HIV
Harpreet Kaur, William S. Bush, Scott L. Letendre, Ronald J. Ellis, Robert K. Heaton, Stephanie M. Patton, James R. Connor, David C. Samuels, Donald R. Franklin, Todd Hulgan, Asha R. Kallianpur
medRxiv 2020.11.04.20199760; doi: https://doi.org/10.1101/2020.11.04.20199760

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)